2026 NPPES data Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist NPI 1922358134 PHARM D
Verify on CMS →

ERIKA FELIX-GETZIK, PHARM D

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist in NEWTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
540
Medicare Part D claims · 155 beneficiaries · Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist avg: 256
Generic prescribing
80%
generic claims · 20% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

ERIKA FELIX-GETZIK, PHARM D filed 540 Medicare Part D claims in 2023 as a Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist in NEWTON, Massachusetts, prescribing 80% generic.

540
Part D claims, 2023
80%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ERIKA FELIX-GETZIK, PHARM D's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

540 Top 34% higher than 66% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about ERIKA FELIX-GETZIK, PHARM D?

Quality data not reported

NPI registry status

Active

Issued 09/14/2012

NPI 1922358134

Primary specialty

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist

Mid-sized

12,377 US NPIs in this specialty

Medicare Part D claims

540 111% vs specialty avg

2023 prescription claims

Specialty avg: 256

Specialty distribution in Massachusetts

How Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist compares to other specialties among Massachusetts providers

Massachusetts providers

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist share within Massachusetts

1. Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist ABMS/AOA estimate

Est. board-certified rate (Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ERIKA FELIX-GETZIK, PHARM D appears in the CMS NPPES registry as a Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist provider holding PHARM D credentials at 2014 WASHINGTON ST, NEWTON, MA, 02111, with a listed phone of (617) 243-5794. NPI 1922358134 was issued on 09/14/2012. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FELIX-GETZIK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 540 prescription claims written by this provider, covering 155 Medicare beneficiaries and totaling roughly $118K in drug spend, split 20% brand-name and 80% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist is a mid-sized specialty nationwide, with 12,377 enrolled providers across 55 states and an average of 256 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2014 WASHINGTON ST
NEWTON, MA 02111

Provider Details

NPI 1922358134
Specialty Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Credentials PHARM D
Gender Female
NPI Issued 09/14/2012

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to ERIKA FELIX-GETZIK, PHARM D. To verify ERIKA FELIX-GETZIK, PHARM D's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

ERIKA FELIX-GETZIK, PHARM D — brand share 20.0%
Specialty average (est.)

20% brand-name claims vs 80% generic, on 540 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

540
Total Claims
$118K
Total Drug Cost
155
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,337
Total Day Supply
39,908
Brand vs Generic
20% brand / 80% generic
Brand Drug Cost
$96K
Generic Drug Cost
$22K

Patient Demographics

Average Patient Age
75.6 years
Avg HCC Risk Score
1.11
Gender Split
63% female / 37% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ERIKA FELIX-GETZIK, PHARM D prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Rosuvastatin Calcium
61
Carvedilol
60
Ezetimibe
49
Felodipine Er
Felodipine
44
Praluent Pen
Alirocumab
42
Atorvastatin Calcium
28
Repatha Sureclick
Evolocumab
25
Pravastatin Sodium
24
Losartan Potassium
23
Eliquis
Apixaban
20

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Overview

How ERIKA FELIX-GETZIK, PHARM D fits within the Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist landscape nationally.

12,377
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Providers in US
55
States with Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
256
Avg Claims per Provider

ERIKA FELIX-GETZIK, PHARM D's 540 claims are above the specialty average of 256.

Nearby Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as FELIX-GETZIK.

Compare Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is ERIKA FELIX-GETZIK, PHARM D's specialty?
ERIKA FELIX-GETZIK, PHARM D specializes in Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist and practices in NEWTON, Massachusetts. Credentials: PHARM D.
How much does ERIKA FELIX-GETZIK, PHARM D prescribe under Medicare Part D?
In 2023, ERIKA FELIX-GETZIK, PHARM D wrote 540 Medicare Part D claims totaling $118K in drug costs for 155 beneficiaries.
Where is ERIKA FELIX-GETZIK, PHARM D located?
ERIKA FELIX-GETZIK, PHARM D is located at 2014 WASHINGTON ST, NEWTON, MA, 02111. Phone: (617) 243-5794.
What is ERIKA FELIX-GETZIK, PHARM D's NPI number?
ERIKA FELIX-GETZIK, PHARM D's National Provider Identifier (NPI) is 1922358134, issued on 09/14/2012.
Does ERIKA FELIX-GETZIK, PHARM D prescribe more brand-name or generic drugs?
ERIKA FELIX-GETZIK, PHARM D's prescribing is 20% brand-name and 80% generic drugs by claim count, with $96K in brand drug costs.
How many Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist providers are there in the US?
There are 12,377 Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist providers across 55 states in the US. The average Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist provider writes 256 Medicare Part D claims per year.
What drugs does ERIKA FELIX-GETZIK, PHARM D prescribe most often?
Based on 2023 Medicare Part D data, ERIKA FELIX-GETZIK, PHARM D's most frequently prescribed drugs include Rosuvastatin Calcium, Carvedilol, Ezetimibe. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ERIKA FELIX-GETZIK, PHARM D accept Medicare?
ERIKA FELIX-GETZIK, PHARM D appears in CMS Medicare data with 540 Part D claims and 155 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ERIKA FELIX-GETZIK, PHARM D's credentials?
ERIKA FELIX-GETZIK, PHARM D's NPI is 1922358134 with credentials PHARM D. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology